LICENSE AGREEMENT Carnegie Mellon University – NeuBase Therapeutics, Inc.License Agreement • May 7th, 2019 • Ohr Pharmaceutical Inc • Pharmaceutical preparations • Pennsylvania
This Agreement (hereinafter “this Agreement”) entered into as of 17th day of December, 2018 (“Effective Date”) by and between Carnegie Mellon University, a Pennsylvania not-for- profit corporation, having a principal place of business at 5000 Forbes Avenue, Pittsburgh, PA (“Carnegie Mellon”) and NeuBase Therapeutics, Inc. a Delaware corporation, having a principal place of business at 2730 Sidney Street, Suite 300, Pittsburgh, PA 15203 (“Licensee”).
NEUBASE THERAPEUTICS, INC. EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 7th, 2019 • Ohr Pharmaceutical Inc • Pharmaceutical preparations • Pennsylvania
THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of December 22, 2018 by and between NeuBase Therapeutics, Inc. (the “Company”), and Dietrich A. Stephan (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”) and is effective as of August 28, 2018 (the “Effective Date”).
AT-WILL EMPLOYMENT, CONFIDENTIAL INFORMATION, INVENTION ASSIGNMENT, AND ARBITRATION AGREEMENTAt-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement • May 7th, 2019 • Ohr Pharmaceutical Inc • Pharmaceutical preparations • Pennsylvania
As a condition of my employment with NeuBase Therapeutics, Inc. (the “Company”), and in consideration of my employment with the Company and my receipt of the compensation now and hereafter paid to me by Company, I agree to the following provisions of this At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement (this “Agreement”).
